(CNY) HSBC MSCI China - Ratings and Ratios
Chinese, Equities, Diversified, Exposure, Market
Description: CNY HSBC MSCI China
The HSBC MSCI China UCITS ETF (CNY) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. With its domicile in France, this ETF is designed to cater to investors seeking to tap into Chinas growth potential.
From a technical standpoint, the ETFs price is currently at 6.42, slightly below its 20-day simple moving average (SMA) of 6.51, indicating a potential short-term bearish trend. However, its 50-day SMA is at 6.42, suggesting a stable medium-term outlook. The 200-day SMA at 6.33 provides a bullish long-term indication. The average true range (ATR) of 0.09 (1.44%) suggests moderate volatility. Given these technical indicators, a potential trading range could be between 6.20 and 6.60.
Fundamentally, the ETF has assets under management (AUM) of 924.73 million EUR, indicating a reasonable level of investor interest. As the fund tracks the Morningstar China TME NR USD index, its performance is closely tied to the overall Chinese equity market. Chinas economic growth, driven by factors such as government initiatives, technological advancements, and increasing consumer spending, is likely to positively impact the ETFs performance.
Combining both technical and fundamental analysis, a forecast for the HSBC MSCI China UCITS ETF (CNY) could be as follows: Given the current technical indicators and the ETFs tracking of the Chinese equity market, we could see the price stabilize around 6.40-6.50 in the short term. If the Chinese economy continues to grow and investor sentiment remains positive, the ETF could potentially break through the 52-week high of 7.34 in the long term, reaching 7.80 or higher. Conversely, if theres a downturn in the Chinese market or global economic conditions deteriorate, the price could fall towards the 52-week low of 4.90. Therefore, investors should closely monitor both the technical trends and fundamental factors influencing the Chinese equity market.
Additional Sources for CNY ETF
CNY ETF Overview
Market Cap in USD | 1,089m |
Category | China Equity |
TER | 0.28% |
IPO / Inception | 2011-01-26 |
CNY ETF Ratings
Growth Rating | -14.1 |
Fundamental | - |
Dividend Rating | 61.2 |
Rel. Strength | 10.3 |
Analysts | - |
Fair Price Momentum | 6.30 EUR |
Fair Price DCF | - |
CNY Dividends
Dividend Yield 12m | 3.01% |
Yield on Cost 5y | 2.43% |
Annual Growth 5y | 18.14% |
Payout Consistency | 88.5% |
Payout Ratio | % |
CNY Growth Ratios
Growth Correlation 3m | 43.3% |
Growth Correlation 12m | 70.3% |
Growth Correlation 5y | -63.8% |
CAGR 5y | -3.86% |
CAGR/Max DD 5y | -0.07 |
Sharpe Ratio 12m | -0.27 |
Alpha | 15.09 |
Beta | 0.583 |
Volatility | 21.64% |
Current Volume | 25.3k |
Average Volume 20d | 21.9k |
Stop Loss | 6.3 (-3.2%) |
As of July 09, 2025, the stock is trading at EUR 6.51 with a total of 25,349 shares traded.
Over the past week, the price has changed by +0.51%, over one month by -2.12%, over three months by +11.12% and over the past year by +26.33%.
Neither. Based on ValueRay´s Analyses, HSBC MSCI China is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -14.11 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNY is around 6.30 EUR . This means that CNY is currently overvalued and has a potential downside of -3.23%.
HSBC MSCI China has no consensus analysts rating.
According to our own proprietary Forecast Model, CNY HSBC MSCI China will be worth about 7.1 in July 2026. The stock is currently trading at 6.51. This means that the stock has a potential upside of +9.52%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.1 | 9.5% |